Age-Related Macular Degeneration (ADM) is the leading cause of severe
vision loss in adults over age 50. The Centers for Disease Control and
Prevention estimate that 1.8 million people have AMD and another 7.3
million are at substantial risk for vision loss from AMD. Caucasians are
at higher risk for developing AMD than other races. Women also develop
AMD at an earlier age than men. This eye disease occurs when there are
changes to the macula, a small portion of the retina that is located on
the inside back layer of the eye. AMD is a loss of central vision that
can occur in two forms: “dry” or atrophic and “wet” or exudative.
Most people with macular degeneration have the dry form, for which
there is no known treatment. The less common wet form may respond to
laser procedures, or drug treatments (injections) if diagnosed and
treated early.
Some common symptoms are: a gradual loss of ability to see objects
clearly, distorted vision, a gradual loss of color vision, and a dark or
empty area appearing in the center of vision. If you experience any of
these, contact your doctor of optometry immediately for a comprehensive
examination. Central vision that is lost to macular degeneration cannot
be restored. However, low vision devices, such as telescopic and
microscopic lenses, can be prescribed to maximize existing vision.
Researchers have linked eye-friendly nutrients such as
lutein/zeaxanthin, vitamin C, vitamin E, and zinc to reducing the risk
of certain eye diseases, including macular degeneration. For more
information on the importance of good nutrition and eye health, please
see the diet and nutrition section.
Symptoms of AMD
Gradual loss of ability to see objects clearly
Objects appear distorted in shape. Straight lines look wavy or crooked.
Loss of clear color vision
A dark or empty area appears in the center of vision.
Gradual loss of ability to see objects clearly
Objects appear distorted in shape. Straight lines look wavy or crooked.
Loss of clear color vision
A dark or empty area appears in the center of vision.
No comments:
Post a Comment